Hookipa Pharma Delists Common Stock
Hookipa Pharma is delisting from Nasdaq and deregistering its common stock, a move closely tied to its recent asset...
eClinical Tech News
i-Mab Strengthens Givastomig IP Portfolio Through Acquisition
I-Mab’s acquisition of Bridge Health Biotech signals a strategic move to solidify its position in the increasingly competitive Claudin...
Veraxa & Voyager Merger: Form F-4 Filed with SEC
Veraxa Biotech, an emerging player in next-generation antibody-based cancer therapies, has filed an F-4 registration statement with the SEC,...
nkgen Biotech Secures Funding to Regain Compliance
NKGen Biotech Secures $2 Million, Aiming for Nasdaq Return After Tumultuous Period NKGen Biotech, a clinical-stage company developing NK...
60 Degrees Pharmaceuticals Closes $10M Public Offering
60 Degrees Pharmaceuticals Bolsters Cash Runway with $5 Million Public Offering 60 Degrees Pharmaceuticals has closed a public offering,...
Tevogen.ai Awarded International AI Patent for Immunological Peptide Prediction
Tevogen Secures Key AI Patent, Signaling Broader Shift in Biopharma R&D Tevogen has secured a patent for its AI-driven...
Ioavance Biotherapeutics Announces Inducement Grants
Iovance Biotherapeutics, a prominent player in the burgeoning field of tumor-infiltrating lymphocyte (TIL) therapies, recently granted stock options to...
Tevogen.ai Secures Patent for AI Immunological Peptide Prediction Technology
Tevogen Bio Holdings (Nasdaq: TVGN) has secured a patent for its machine learning-driven system designed to predict immunologically active...
eurneffy® Nasal Spray: First Needle-Free Anaphylaxis Treatment in U.K.
ARS Pharmaceuticals has secured UK approval for Eurneffy, its needle-free adrenaline nasal spray for anaphylaxis in adults and children...
ICT01 Awarded FDA Orphan Drug Designation for AML Treatment
ImCheck Therapeutics’ lead candidate, ict01, has received FDA orphan drug designation for acute myeloid leukemia (AML). This regulatory win...